Microorganisms having enhanced L-amino acids productivity and process for producing L-amino acids using the same

US10113191B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10113191-B2
Application numberUS-201515112855-A
CountryUS
Kind codeB2
Filing dateMar 17, 2015
Priority dateMar 21, 2014
Publication dateOct 30, 2018
Grant dateOct 30, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are a recombinant microorganism having enhanced L-amino acid productivity, wherein the recombinant microorganism is transformed to have removed or decreased activity of at least one of adenosine deaminase and AMP nucleosidase, and a method of producing an L-amino acid using the recombinant microorganism. The use of the recombinant microorganism may enable the production of the L-amino acid in a highly efficient manner.

First claim

Opening claim text (preview).

The invention claimed is: 1. A recombinant microorganism, wherein activity of at least one of adenosine deaminase comprising the amino acid sequence of SEQ ID NO: 14 and AMP nucleosidase comprising the amino acid sequence of SEQ ID NO: 16 is removed or decreased compared to that of a mother strain, wherein the recombinant microorganism belongs to the genus Escherichia and has enhanced producibility of an L-amino acid compared to that of the mother strain, wherein the L-amino acid is L-threonine or L-tryptophan, and wherein the recombinant microorganism does not contain chloramphenicol marker gene. 2. The recombinant microorganism of claim 1 , wherein the recombinant microorganism is Escherichia coli. 3. The recombinant microorganism of claim 1 , wherein activity of adenosine deaminase comprising the amino acid sequence of SEQ ID NO: 14 and AMP nucleosidase comprising the amino acid sequence of SEQ ID NO: 16 are removed or decreased compared to that of the mother strain. 4. The recombinant microorganism of claim 1 , wherein at least one of a gene encoding adenosine deaminase comprising the amino acid sequence of SEQ ID NO: 14 and a gene encoding AMP nucleosidase comprising the amino acid sequence of SEQ ID NO: 16 is deleted or modified to be disrupted. 5. The recombinant microorganism of claim 4 , wherein at least one of the genes is modified such that a part or all of the gene or regulatory factors on promoter or terminator regions of the genes are mutated, substituted, deleted, or inserted. 6. A method of producing L-amino acid, the method comprising: culturing a recombinant microorganism; and collecting an L-amino acid from the culture, wherein the L-amino acid is L-threonine or L-tryptophan, wherein the recombinant microorganism has an activity of at least one of adenosine deaminase comprising the amino acid sequence of SEQ ID NO:14 and AMP nucleosidase comprising the amino acid sequence of SEQ ID NO:16 removed or decreased compared to that of a mother strain, does not contain chloramphenical marker gene, and has enhanced producibility of L-threonine or L-tryptophan compared to that of the mother strain. 7. The method of claim 6 , wherein the recombinant microorganism is an Escherichia. 8. The method of claim 6 , wherein the recombinant microorganism is an Escherichia coli. 9. The method of claim 6 , wherein activity of adenosine deaminase comprising the amino acid sequence of SEQ ID NO: 14 and AMP nucleosidase comprising the amino acid sequence of SEQ ID NO: 16 in the recombinant microorganism are removed or decreased compared to that of the mother strain. 10. The method of claim 6 , wherein at least one of a gene encoding adenosine deaminase comprising the amino acid sequence of SEQ ID NO: 14 and a gene encoding AMP nucleosidase comprising the amino acid sequence of SEQ ID NO: 16 in the recombinant microorganism is deleted or modified to be disrupted. 11. The method of claim 10 , wherein at least one of the genes is modified such that a part or all of the genes or regulatory factors on promoter or terminator regions of the genes are mutated, substituted, deleted, or inserted.

Assignees

Inventors

Classifications

  • C12N1/20Primary

    Bacteria; Culture media therefor · CPC title

  • Alpha- or beta- amino acids {(other amino acids C12P13/005)} · CPC title

  • Adenosine deaminase (3.5.4.4) · CPC title

  • acting on carbon to nitrogen bonds other than peptide bonds (3.5) · CPC title

  • C12P13/227Primary

    Tryptophan · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10113191B2 cover?
Disclosed are a recombinant microorganism having enhanced L-amino acid productivity, wherein the recombinant microorganism is transformed to have removed or decreased activity of at least one of adenosine deaminase and AMP nucleosidase, and a method of producing an L-amino acid using the recombinant microorganism. The use of the recombinant microorganism may enable the production of the L-amino…
Who is the assignee on this patent?
Cj Cheiljedang Corp
What technology area does this patent fall under?
Primary CPC classification C12N1/20. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).